HIGHLIGHTS
- who: Matthew M. Gayed and collaborators from the Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA have published the research: Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease, in the Journal: (JOURNAL) of 26/Oct/2022
- what: The authors demonstrate the clinical utility of lyso-Gb1 analysis in four patients with normal CHITO activity after treatment.
- future: Platelet counts continued to measure within the normal range and CHITO activity continued to decline on a downward trend (average 24.8 nmol . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.